Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy

American Journal of Gastroenterology

Volumn 110, Issue 9, 2015, Pages 1359-1366

  Rossi, Paolo Giorgi ^a,b   Vicentini, Massimo ^a,b   Sacchettini, Claudio ^a,b   Di Felice, Enza ^a,b   Caroli, Stefania ^a,b   Ferrari, Francesca ^a,b   Mangone, Lucia ^a,b   Pezzarossi, Annamaria ^a,b   Roncaglia, Francesca ^a,b   Campari, Cinzia ^a,b   Sassatelli, Romano ^b   Sacchero, Roberto ^a   Sereni, Giuliana ^b   Paterlini, Luisa ^a   Zappa, Marco ^c  

^a PATHOLOGY UNIT   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c Regional Reference Center for Cancer Screening   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; ITALY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGRAM EFFICACY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; INCIDENCE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROGRAM EVALUATION; REGISTER; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TRENDS;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; MALE; MASS SCREENING; MIDDLE AGED; PROGRAM EVALUATION; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84941259549     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.240     Document Type: Article

References (40)

1. IARC. Globocan 2012. Cancer fact sheet: Colorectal Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012. Available at http:// globocan. iarc. fr/Pages/fact-sheets-cancer. aspx.
2. Mandel JS, Bond TH, Church TR et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 1993; 328: 1365-71.
3. Hardcastle JD, Chamberlain LO, Robinson MHE et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996; 348: 1472-77.
4. Kewenter J, Brevinge H, Engaras B et al. Results of screening, rescreening, and follow-up in a prospective, randomized study for the detection of colorectal cancer by fecal occult blood testing. Results for 68308 subjects. Scand J Gastroenterol 1994; 29: 468-73.
5. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996; 348: 1467-71.
6. Hewitson P, Glasziou PP, Irwig L et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; 24: CD001216-Review.
7. Dancourt V, Lejeune C, Lepage C et al. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008; 44: 2254-58.
8. Guittet L, Bouvier V, Mariotte N et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007; 56: 210-14.
9. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90.
10. Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer 2013; 49: 3049-54.
11. Faivre J, Dancourt V, Denis B et al. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer. Eur J Cancer 2012; 48: 2969-76.
12. Raginel T, Puvinel J, Ferrand O et al. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening. Gastroenterology 2013; 144: 918-25.
13. Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW et al. Colonoscopycontrolled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Aliment Pharmacol Th er 2010; 31: 432-39.
14. Smith A, Young GP, Cole SR et al. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiacbased fecal occult blood test in detection of colorectal neoplasia. Cancer 2006; 107: 2152-59.
15. Segnan N, Patnick J, von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis, 1st edn. Publications Offi ce of the European Union: Luxembourg, 2010.
16. Zorzi M, Fedeli U, Schievano E et al. Impact on colorectal cancer mortality of screening programmemes based on the faecal immunochemical test. Gut 2014; 64: 784-90.
17. Hoff G, Grotmol T, Skovlund E et al. for the Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years aft er fl exible sigmoidoscopy screening: randomised controlled trial. BMJ 2009; 338: b1846.
18. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only fl exible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624-33.
19. Segnan N, Armaroli P, Bonelli L et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up fi ndings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst 2011; 103: 1310-22.
20. Schoen RE, Pinsky PF, Weissfeld JL et al. Colorectal-cancer incidence and mortality with screening fl exible sigmoidoscopy. N Engl J Med 2012; 366: 2345-57.
21. Brenner H, Stock C, Hoff meister M. Eff ect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014; 348: g2467.
22. Ventura L, Mantellini P, Grazzini G et al. Th e impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis 2014; 46: 82-6.
23. Atkin WS, Saunders BP. British Society for Gastroenterology. Association of Coloproctology for Great Britain and Ireland. Surveillance guidelines aft er removal of colorectal adenomatous polyps. Gut 2002; 51 Suppl 5: V6-9.
24. Jensen OM, Storm HH. Cancer registration: principles and methods. Reporting of results. IARC Sci Publ 1991; 95: 108-25.
25. Baili P, Vicentini M, Tumino R et al. Amethod for diff erentiating cancer prevalence according to health status,exemplifi ed using a population-based sample of Italian colorectal cancer cases. Acta Oncol 2013; 52: 294-302.
26. Kim HJ, Fay MP, Feuer EJ et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51 (correction: 2001;20:655).
27. Surveillance Research Program, National Cancer Institute SEER Stat soft-ware seer. cancer. gov/seerstat version 8. 1. 5.
28. Resident Population. Downloaded from http://demo. istat. it.
29. Campari C, Sassatelli R, Paterlini L et al. Test and programme sensitivities of screening for colorectal cancer in Reggio Emilia. Epidemiol Prev 2011; 35: 118-24.
30. Costantini AS, Martini A, Puliti D et al. Colorectal cancer mortality in two areas of Tuscany with diff erent screening exposures. J Natl Cancer Inst 2008; 100: 1818-21.
31. Faivre J, Dancourt V, Lejeune C et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126: 1674-80.
32. Libby G, Brewster DH, McClements PL et al. Th e impact of populationbased faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer 2012; 107: 255-59.
33. Mandel JS, Church TR, Bond JH et al. Th e eff ect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-07.
34. Crocetti E, Buzzoni C, Zappa M. Colorectal cancer incidence rates have decreased in central Italy. Eur J Cancer Prev 2010; 19: 424-25.
35. Sunkara V, Hebert JR. Th e colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care. Cancer 2015; 121: 1563-69.
36. Sakata N, Sakata Y, Shimoda R et al. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan. Hepatogastroenterology 2014; 61: 1224-28.
37. AIRTUM Working Group. Italian cancer fi gures, report 2009: Cancer trend (1998-2005). Epidemiol Prev 2009; 33: 38-9.
38. Sankaranarayanan R. Screening for cancer in low-and middle-income countries. Ann Glob Health 2014; 80: 412-17.
39. Waller J, Osborne K, Wardle J. Enthusiasm for cancer screening in Great Britain: a general population survey. Br J Cancer 2014; 112: 562-66.
40. Kranse R, van Leeuwen PJ, Hakulinen T et al. Excess all-cause mortality in the evaluation of a screening trial to account for selective participation. J Med Screen 2013; 20: 39-45.